Bradford Thompson

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Magdy Selim, Lydia D. Foster, Claudia S. Moy et al. · The Lancet Neurology · 2019 · 239 citations · Full text

Thrombosis, Reperfusion Injury, Deferoxamine Mesylate +11

Variability in physician prognosis and recommendations after intracerebral hemorrhage

Darin B. Zahuranec, Angela Fagerlin, Brisa N. Sánchez et al. · Neurology · 2016 · 76 citations · Full text

Predicting symptomatic intracranial haemorrhage after mechanical thrombectomy: the TAG score

Mayra Montalvo, Eva Mistry, Andrew Chang et al. · Journal of Neurology Neurosurgery & Psychiatry · 2019 · 70 citations

Post–Acute Care Data for Predicting Readmission After Ischemic Stroke: A Nationwide Cohort Analysis Using the Minimum Data Set

Corey R. Fehnel, Yoojin Lee, Linda C. Wendell et al. · Journal of the American Heart Association · 2015 · 51 citations · Full text

Deconstructing Poststroke Delirium in a Prospective Cohort of Patients With Intracerebral Hemorrhage*

Michael Reznik, Jonathan Drake, Seth A. Margolis et al. · Critical Care Medicine · 2019 · 44 citations